Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver diseaseLukas Hartl, Michael Trauner, Benedikt Simbrunner et al.|Hepatology|2022Cited by 74
Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomasHannes Vietzen, Elisabeth Puchhammer‐Stöckl, Philipp B. Staber et al.|Frontiers in Immunology|2023Cited by 16
The natural killer cell‐associated rs9916629 <i>‐</i> C allele is a novel genetic risk factor for fatal COVID‐19Hannes Vietzen, Elisabeth Puchhammer‐Stöckl, Alexander Zoufaly et al.|Journal of Medical Virology|2022Cited by 9